HAC Treatment Planning & Management 2 — Questions and Answers
Question 1: Which regulatory framework requires that inpatient treatment plans be reviewed and updated at specified intervals to reflect patient progress?
- HIPAA Privacy Rule
- Conditions of Participation (CoP) (Correct answer)
- EMTALA
- Anti-Kickback Statute
Correct answer: Conditions of Participation (CoP)
CMS Conditions of Participation require hospitals to review and update treatment plans at defined intervals to ensure care remains appropriate and goal-directed.
Question 2: A healthcare analyst reviewing care coordination data finds that patients with chronic conditions who receive integrated treatment plans have 22% fewer readmissions. This outcome best supports which care model?
- Fee-for-service reimbursement
- Patient-Centered Medical Home (PCMH) (Correct answer)
- Retrospective case management
- Single-payer insurance
Correct answer: Patient-Centered Medical Home (PCMH)
The PCMH model emphasizes coordinated, patient-centered care with integrated treatment planning, which is associated with reduced readmissions for chronic disease patients.
Question 3: When a treatment plan includes a medication with a narrow therapeutic index, what monitoring element is most critical to document?
- Patient's insurance formulary tier
- Serum drug level and adverse effect surveillance schedule (Correct answer)
- Prescriber's DEA number
- Pharmacy dispensing location
Correct answer: Serum drug level and adverse effect surveillance schedule
Narrow therapeutic index drugs require documented serum level monitoring and adverse effect surveillance because small dose changes can cause toxicity or treatment failure.
Question 4: In utilization management, a concurrent review of a treatment plan primarily aims to:
- Audit historical billing records
- Determine medical necessity for continued inpatient stay (Correct answer)
- Credential the treating physician
- Assess payer contract compliance
Correct answer: Determine medical necessity for continued inpatient stay
Concurrent review evaluates whether an ongoing inpatient stay and treatment plan meet medical necessity criteria to justify continued authorization.
Question 5: Which metric best measures the effectiveness of a treatment planning process in reducing clinical variation?
- Average patient satisfaction score
- Clinical pathway adherence rate (Correct answer)
- Number of outpatient referrals generated
- Payer mix distribution
Correct answer: Clinical pathway adherence rate
Clinical pathway adherence rate measures how consistently providers follow evidence-based treatment plans, directly reflecting reduction in unwarranted clinical variation.
Question 6: A patient refuses a recommended component of their treatment plan. The most appropriate documentation step is to record:
- The refusal as non-compliance and flag for discharge
- Informed refusal, alternatives offered, and patient's stated reasoning (Correct answer)
- Only the final agreed-upon plan without noting the refusal
- A mandatory incident report to risk management
Correct answer: Informed refusal, alternatives offered, and patient's stated reasoning
Documenting informed refusal — including alternatives discussed and patient reasoning — protects the patient's autonomy and the provider's legal standing.
Question 7: Which data source is most useful to a healthcare analyst benchmarking treatment planning length-of-stay against national standards?
- CMS Medicare Provider Analysis and Review (MedPAR) data (Correct answer)
- State vital statistics registry
- IRS Form 990 filings
- Joint Commission survey reports
Correct answer: CMS Medicare Provider Analysis and Review (MedPAR) data
MedPAR data contains inpatient claim-level detail including diagnoses, procedures, and length of stay, making it the standard benchmarking source for LOS analysis.
HAC Treatment Planning & Management 2
Which regulatory framework requires that inpatient treatment plans be reviewed and updated at specified intervals to reflect patient progress?